$2.06
0.06[3.00%]
At close: Apr 19
$2.06
0[0.00%]
After Hours: 7:47PM EDT
Coherus BioSciences
(NASDAQ:CHRS)Latest News for Coherus BioSciences Stock (NASDAQ:CHRS)
Coherus BioSciences Stock (NASDAQ: CHRS)
Categories: All
Monday, April 08, 2024
Wednesday, March 20, 2024
Thursday, March 14, 2024
Wednesday, March 13, 2024
- Coherus BioSciences shares are trading lower after the company reported worse-than-expected Q4 financial results.Benzinga Newsdesk - Mar 13, 2024, 4:34PM
- Coherus BioSciences Sees FY24 R&D And SG&A Expenses $250M-$265MBenzinga Newsdesk - Mar 13, 2024, 4:25PM
- Recap: Coherus BioSciences Q4 EarningsBenzinga Insights - Mar 13, 2024, 4:05PM
- Coherus BioSciences Q4 2023 Adj EPS $(0.62) Misses $(0.12) Estimate, Sales $91.524M Miss $96.400M EstimateBenzinga Newsdesk - Mar 13, 2024, 4:03PM
- Earnings Scheduled For March 13, 2024Benzinga Insights - Mar 13, 2024, 6:15AM
Tuesday, March 12, 2024
Wednesday, February 21, 2024
Tuesday, January 23, 2024
- Baird Maintains Outperform on Coherus BioSciences, Lowers Price Target to $9Benzinga Newsdesk - Jan 23, 2024, 3:05PM
- Truist Securities Maintains Buy on Coherus BioSciences, Lowers Price Target to $8-Report Released on 22 January 2024Benzinga Newsdesk - Jan 23, 2024, 7:53AM
- Truist Securities Maintains Buy on Coherus BioSciences, Lowers Price Target to $8Benzinga Newsdesk - Jan 23, 2024, 7:50AM
Monday, January 22, 2024
- Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Jan 22, 2024, 1:08PM
- Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today?Vandana Singh - Jan 22, 2024, 9:41AM
- Market-Moving News for January 22ndBenzinga Newsdesk - Jan 22, 2024, 8:55AM
- Why Coherus BioSciences Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Jan 22, 2024, 8:21AM
- Coherus BioSciences shares are trading higher after the company agreed to divest its Cimerli ophthalmology franchise to Sandoz for $170 million plus an additional amount for inventory.Benzinga Newsdesk - Jan 22, 2024, 7:19AM
- CORRECTION: Coherus To Divest Ophthalmology Franchise To Sandoz In $170M Cash DealBenzinga Newsdesk - Jan 22, 2024, 7:15AM
- Coherus Earlier Announced Agreement To Divest Ophthalmology Franchise Cimerli To Novarts' Sandoz Unit For $170M Upfront All Cash DealCharles Gross - Jan 22, 2024, 5:29AM
- Coherus To Divest Ophthalmology Franchise To Sandoz In $170M Cash DealBenzinga Newsdesk - Jan 22, 2024, 1:44AM
Friday, January 19, 2024
Thursday, January 18, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Jan 18, 2024, 4:31PM
- Coherus Presents Phase 2 Clinical Data On Casdozokitug, A First-in-Class IL-27-Targeted Antibody, At The 2024 ASCO GI Cancers Symposium; The Primary Endpoint Of The Lead-in Portion Of The Study Was Safety And TolerabilityBenzinga Newsdesk - Jan 18, 2024, 4:16PM
Wednesday, January 10, 2024
- Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On WednesdayAvi Kapoor - Jan 10, 2024, 10:27AM
- Coherus Biosciences Has Announced The Termination Of Its Tigit Program Collaboration With Shanghai Junshi Biosciences, With Plans To Wind Down Their Work In The Coming MonthsCharles Gross - Jan 10, 2024, 6:09AM
Thursday, January 04, 2024
Tuesday, January 02, 2024
- Coherus BioSciences shares are trading higher after the company announced the U.S. launch of LOQTORZI.Benzinga Newsdesk - Jan 2, 2024, 11:46AM
- Coherus Announces U.S. Launch Of LOQTORZI; Offers First And Only FDA-Approved Treatment For NPC In All Lines Of TherapyBenzinga Newsdesk - Jan 2, 2024, 8:31AM
Friday, December 29, 2023
Wednesday, December 27, 2023
- Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike HigherAvi Kapoor - Dec 27, 2023, 2:19PM
- Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Dec 27, 2023, 2:11PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Dec 27, 2023, 12:31PM
- Gold Gains 1%; Richmond Fed Manufacturing Index Falls In DecemberAvi Kapoor - Dec 27, 2023, 12:27PM
- Why Coherus BioSciences Stock Is Climbing TodayErica Kollmann - Dec 27, 2023, 11:54AM
- US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODYAvi Kapoor - Dec 27, 2023, 9:56AM
- Coherus BioSciences shares are trading higher after the company announced FDA approval of UDENYCA ONBODY for pegfilgrastim-cbqv.Benzinga Newsdesk - Dec 27, 2023, 8:46AM
- Why Ascent Industries Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Dec 27, 2023, 8:14AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Dec 27, 2023, 8:07AM
- S&P 500, Nasdaq Set For Wobbly Open As Santa Claus Rally Fades: Analyst Sees Final Trading Sessions As 'Last Great Buying Opportunity'Shanthi Rexaline - Dec 27, 2023, 7:35AM
- Coherus BioSciences And Other Big Stocks Moving Higher In Wednesday's Pre-Market SessionAvi Kapoor - Dec 27, 2023, 6:08AM
- HC Wainwright & Co. Reiterates Buy on Coherus BioSciences, Maintains $13 Price TargetBenzinga Newsdesk - Dec 27, 2023, 6:06AM
- Coherus BioSciences, Ascent Industries And 3 Stocks To Watch Heading Into WednesdayAvi Kapoor - Dec 27, 2023, 4:17AM
Tuesday, December 26, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Dec 26, 2023, 4:31PM
- Coherus BioSciences Stock Is Soaring After-Hours - Here's WhyRyan Gustafson - Dec 26, 2023, 4:30PM
- Coherus BioSciences shares are trading higher after the company announced FDA approval of UDENYCA ONBODY for pegfilgrastim-cbqv.Benzinga Newsdesk - Dec 26, 2023, 4:05PM
- Coherus Biosciences Announced That The FDA Approved UDENYCA ONBODY, The Company's On-Body Injector Presentation Of UDENYCABenzinga Newsdesk - Dec 26, 2023, 4:03PM